| |
| |
|
| Insider
Information: |
Pascoe Richard W |
| Relationship: |
President, CEO & Direc... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
215,369 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$165,189 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
215,369 |
|
|
| Total
Value |
$165,189 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -4.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Somaxon Pharmaceuticals, Inc. |
SOMX |
President and CEO, Dir... |
2013-03-06 |
0 |
2008-11-28 |
0 |
Premium* |
|
|
Seelos Therapeutics Inc |
SEEL |
CEO & Secretary, Direc... |
2019-01-23 |
155,396 |
2013-05-23 |
0 |
Premium* |
|
|
Kempharm, Inc |
KMPH |
Chief Executive Office... |
2023-03-09 |
29,973 |
2019-05-10 |
0 |
Premium* |
|
|
Histogen Inc |
HSTO |
President, CEO & Direc... |
2021-03-30 |
30,000 |
2020-12-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KMPH |
Kempharm, Inc |
Chief Executive Officer |
• • – |
2023-03-09 |
4 |
B |
$4.20 |
$41,978 |
D/D |
10,000 |
29,973 |
2.81 |
% |
|
| KMPH |
Kempharm, Inc |
Chief Executive Officer |
• • – |
2023-01-13 |
4 |
B |
$5.44 |
$51,679 |
D/D |
9,500 |
19,973 |
2.81 |
% |
|
| KMPH |
Kempharm, Inc |
Executive Chairman |
• • – |
2022-05-18 |
4 |
B |
$4.90 |
$24,608 |
D/D |
5,000 |
8,285 |
2.81 |
% |
|
| KMPH |
Kempharm, Inc |
Executive Chairman |
• • – |
2021-11-30 |
4 |
B |
$7.88 |
$11,822 |
D/D |
1,500 |
3,285 |
2.81 |
% |
|
| HSTO |
Histogen Inc |
President, CEO & Director |
• • – |
2021-03-30 |
4 |
B |
$1.14 |
$22,800 |
D/D |
20,000 |
30,000 |
2.81 |
- |
|
| HSTO |
Histogen Inc |
President, CEO & Director |
• • – |
2020-12-03 |
4 |
B |
$1.24 |
$12,394 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
| KMPH |
Kempharm, Inc |
Director |
• • – |
2020-08-18 |
4 |
B |
$0.63 |
$6,352 |
D/D |
10,000 |
28,573 |
2.39 |
- |
|
| KMPH |
Kempharm, Inc |
Director |
• • – |
2019-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,928 |
18,573 |
0 |
- |
|
| KMPH |
Kempharm, Inc |
Director |
• • – |
2019-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
9,645 |
9,645 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
CEO & Secretary |
• • – |
2019-01-23 |
4 |
D |
$0.23 |
$10,149 |
D/D |
(44,810) |
155,396 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
CEO & Secretary |
• • – |
2018-11-30 |
4 |
D |
$0.31 |
$5,291 |
D/D |
(17,290) |
200,206 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
CEO & Secretary |
• • – |
2018-01-01 |
4 |
D |
$1.84 |
$14,129 |
D/D |
(7,679) |
217,496 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
CEO & Secretary |
• • – |
2017-09-05 |
4 |
D |
$1.56 |
$29,312 |
D/D |
(18,790) |
225,175 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
CEO & Secretary |
• • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
243,965 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
CEO & Secretary |
• • – |
2017-02-15 |
4 |
D |
$2.78 |
$10,319 |
D/D |
(3,712) |
143,965 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
CEO & Secretary |
• • – |
2017-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
147,677 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
CEO & Secretary |
• • – |
2016-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
350,000 |
476,778 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
CEO & Secretary |
• • – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
79,778 |
126,778 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Chief Executive Officer |
• • – |
2014-12-22 |
4 |
B |
$1.02 |
$10,217 |
D/D |
10,000 |
47,000 |
2.81 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Chief Executive Officer |
• • – |
2014-10-22 |
4 |
B |
$1.51 |
$18,120 |
D/D |
12,000 |
37,000 |
2.81 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Chief Executive Officer |
• • – |
2013-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
25,000 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Chief Executive Officer |
• • – |
2013-05-23 |
4 |
B |
$2.85 |
$99,750 |
D/D |
35,000 |
35,000 |
2.81 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2013-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(98,294) |
0 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2012-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,142 |
104,927 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2012-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
104,035 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
